Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products

Science of the Total Environment

Volumn 372, Issue 1, 2006, Pages 87-93

  Allmyr, Mats ^a,b   Adolfsson Erici, Margaretha ^b   McLachlan, Michael S ^b   Sandborgh Englund, Gunilla ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Antibacterial; Human; Infant; Irgasan

Indexed keywords

BACTERIA; DISEASES; HEALTH RISKS; LIVING SYSTEMS STUDIES; PLASMAS;

ANTIBACTERIAL; HUMAN; INFANTS; IRGASAN;

HEALTH CARE;

COSMETIC; DEODORANT AGENT; DRUG METABOLITE; SOAP; TOOTHPASTE; TRICLOSAN;

BREASTFEEDING; CHEMICAL SUBSTANCE BY USE OR EFFECT; MILK; PLASMA;

ARTICLE; BLOOD ANALYSIS; BREAST MILK; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HUMAN; PLASMA; PRIORITY JOURNAL; RISK ASSESSMENT;

ANTI-INFECTIVE AGENTS, LOCAL; COSMETICS; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; MATERNAL EXPOSURE; MILK, HUMAN; SWEDEN; TRICLOSAN;

EURASIA; EUROPE; NORTHERN EUROPE; SCANDINAVIA; SWEDEN;

EID: 33750976355     PISSN: 00489697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2006.08.007     Document Type: Article

References (22)

1. Adolfsson-Erici M., Pettersson M., Parkkonen J., and Sturve J. Triclosan, a commonly used bactericide found in human milk and in the aquatic environment in Sweden. Chemosphere 46 (2002) 1485-1489
2. Allmyr M., McLachlan M.S., Sandborgh-Englund G., and Adolfsson-Erici M. Determination of triclosan as its pentafluorobenzoyl ester in human plasma and milk using electron capture negative ionization mass spectrometry. Anal Chem (2006) 10.1021/ac060666x
3. Bagley D.M., and Lin Y.J. Clinical evidence for the lack of triclosan accumulation from daily use in dentifrices. Am J Dent 13 (2000) 148-152
4. Bhargava H.N., and Leonard P.A. Triclosan: applications and safety. Am J Infect Control 24 (1996) 209-218
5. Edwardsson S., Burman L., Adolfsson-Erici M., and Backman N. Risker och nytta med triklosan i tandkräm [Risks and benefits with triclosan containing toothpastes]. Tandlakartidningen 97 (2005) 58-64
6. Fleishaker J.C. Models and methods for predicting drug transfer into human milk. Adv Drug Deliv Rev 55 (2003) 643-652
7. Guvenius Meironyté D., Aronsson A., Ekman-Ordeberg G., Bergman A., and Norén K. Human prenatal and postnatal exposure to polybrominated diphenyl ethers, polychlorinated biphenyls, polychlorobiphenylols, and pentachlorophenol. Environ Health Perspect 111 (2003) 1235-1241
8. Hanioka N., Omae E., Nishimura T., Jinno H., Onodera S., Yoda R., et al. Interaction of 2,4,4′-trichloro-2′-hydroxydiphenylether with microsomal cytochrome P450-dependent monooxygenases in rat liver. Chemosphere 33 (1996) 265-276
9. Hovander L., Malmberg T., Athanasiadou M., Athanassiadis I., Rahm S., Bergman A., et al. Identification of hydroxylated PCB metabolites and other phenolic halogenated pollutants in human blood plasma. Arch Environ Contam Toxicol 42 (2002) 105-117
10. Jacobs M.N., Nolan G.T., and Hood S.R. Lignans, bacteriocides and organochlorine compounds activate the human pregnane X receptor (PXR). Toxicol Appl Pharmacol 209 (2005) 123-133
11. Larson E., Aiello A., Lee L.V., Della-Latta P., Gomez-Duarte C., and Lin S. Short-and long-term effects of handwashing with antimicrobial or plain soap in the community. J Community Health 28 (2003) 139-150
12. Lin Y.J. Buccal absorption of triclosan following topical mouthrinse application. Am J Dent 13 (2000) 215-217
13. Merck Index 12:3, 2000.
14. Moss T., Howes D., and Williams F.M. Percutaneous penetration and dermal metabolism of triclosan (2,4,4′-trichloro-2′-hydroxydiphenyl ether). Food Chem Toxicol 38 (2000) 361-370
15. Mustafa M., Wondimu B., Hultenby K., Yucel-Lindberg T., and Modeer T. Uptake, distribution and release of 14C-triclosan in human gingival fibroblasts. J Pharm Sci 92 (2003) 1648-1653
16. Perencevich E.N., Wong M.T., and Harris A.D. National and regional assessment of the antibacterial soap market: a step toward determining the impact of prevalent antibacterial soaps. Am J Infect Control 28 (2001) 281-283
17. Remberger M., Sternbeck J., and Strömberg K. Screening av triclosan och vissa bromerade fenoliska ämnen i Sverige. [Screening of triclosan and some brominated, phenolic compounds in Sweden]. IVL Rapp (2002) B1477-2
18. Sandborgh-Englund G., Adolfsson-Erici M., Odham G., and Ekstrand J. Pharmacokinetics of triclosan following oral ingestion in humans. J Toxicol Environ Health 69 (2006) 1861-1873
19. Schuur A.G., Legger F.F., van Meeteren M.E., Moonen M.J.H., van Leeuwen-Bol I., Bergman A., et al. In vitro inhibition of thyroid hormone sulfation by hydroxylated metabolites of halogenated aromatic hydrocarbons. Chem Res Toxicol 11 (1998) 1075-1081
20. Syracuse Research Corporation. PhysDrop Database Demo. http://www.syrres.com/esc/physdemo.htm [accessed March 2006].
21. The European Commission. Opinion on triclosan resistance, adopted on 27-28 June 2002. http://europa.eu.int/comm/food/fs/sc/ssc/out269_en.pdf [accessed March 2006].
22. Wang L.Q., Falany C.N., and James M.O. Triclosan as a substrate and inhibitor of 3′-phosphoadenosine 5′-phosphosulfate-sulfotransferase and UDP-glucuronosyl transferase in human liver fractions. Drug Metab Dispos 32 (2004) 1162-1169